The anti-calcitonin gene-related peptide (CGRP) monoclonal antibody erenumab (Aimovig) helps patients with chronic migraine convert to an episodic pattern soon after treatment initiation, new research...

Women with a history of migraine are more likely to experience severe or very severe hot flashes than women without migraines, according to research presented Sept. 24 at the hybrid annual meeting of the...

Race and socioeconomic status can hinder and delay patient access to migraine treatment and result in poorer outcomes, according to a study published in the April issue of Headache. People of African descent...